Revision history of "Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions" (Q36832106)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 July 2024

9 July 2024

28 February 2023

11 June 2022

  • curprev 08:3908:39, 11 June 2022 KrBot talk contribs 79,298 bytes −1 Set a claim value: title (P1476): Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions undo (restore)
  • curprev 08:3908:39, 11 June 2022 KrBot talk contribs 79,299 bytes −1 Changed Dutch label: Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions undo (restore)
  • curprev 08:3908:39, 11 June 2022 KrBot talk contribs 79,300 bytes −1 Changed English label: Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions undo (restore)
  • curprev 08:3908:39, 11 June 2022 KrBot talk contribs 79,301 bytes −1 Changed Asturian label: Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions undo (restore)

12 January 2022

22 October 2021

25 July 2021

26 January 2021

26 June 2020

19 April 2020

18 December 2019

21 December 2018

11 December 2018

18 October 2018

13 September 2017

16 August 2017